Protein / target

RNA-directed RNA polymerase L

LQ05318Zaire ebolavirus (strain Mayinga-76)Swiss-Prot
30
Clinical trials
1
Drugs targeting

Protein at a glance

Biological role

MRNA 5'-cap (guanine-N7-)-methyltransferase activity

Derived from structured UniProt, Open Targets and literature data on this page.

Protein profile

UniProt 2026_02

Canonical identity and biological annotation from UniProt.

Function

RNA-directed RNA polymerase that catalyzes the transcription of viral mRNAs, their capping and polyadenylation. The template is composed of the viral RNA tightly encapsidated by the nucleoprotein (N). The viral polymerase binds to the genomic RNA at the 3' leader promoter, and transcribes subsequently all viral mRNAs with a decreasing efficiency. The first gene is the most transcribed, and the last the least transcribed. The viral phosphoprotein acts as a processivity factor. Capping is concomitant with initiation of mRNA transcription. Indeed, a GDP polyribonucleotidyl transferase (PRNTase) adds the cap structure when the nascent RNA chain length has reached few nucleotides. Ribose 2'-O methylation of viral mRNA cap precedes and facilitates subsequent guanine-N-7 methylation, both activities being carried by the viral polymerase. Polyadenylation of mRNAs occur by a stuttering mechanism at a slipery stop site present at the end viral genes. After finishing transcription of a mRNA, the polymerase can resume transcription of the downstream gene

Subcellular location

VirionHost cytoplasm
Domains and Gene Ontology detail (12)

Domains & features

RdRp catalyticMononegavirus-type SAM-dependent 2'-O-MTase

Gene Ontology

  • Chost cell cytoplasm
  • Cvirion component
  • FATP binding
  • FGTPase activity
  • Fmetal ion binding
  • FmRNA 5'-cap (guanine-N7-)-methyltransferase activity
  • FRNA polymerase activity
  • FRNA-directed RNA polymerase activity
  • Pnegative stranded viral RNA replication
  • Pnegative stranded viral RNA transcription

2212 aa · 253 kDa

Biological roles

What this protein does, drawn together from its UniProt function, Gene Ontology terms and Reactome pathways.

Transcriptional regulationUniProt · GOImmune signallingGOMetabolic enzyme activityGO
View supporting evidence

Transcriptional regulation

  • ·RNA-directed RNA polymerase that catalyzes the transcription of viral mRNAs, their cappi…
  • ·negative stranded viral RNA transcription

Immune signalling

  • ·host cell cytoplasm

Metabolic enzyme activity

  • ·mRNA 5'-cap (guanine-N7-)-methyltransferase activity

Concepts derived from UniProt GO Reactome — each badge above shows which sources supported that role.

Drugs targeting this protein

1

Whether each drug engages this protein directly or through a complex, and how many other targets are recorded for it. Direct binders with few recorded targets are listed first.

remdesivir
Narrow target profileInhibitor

RNA-directed RNA polymerase L inhibitor

Direct interaction with this protein · 1 of 2 recorded protein targets — narrow recorded profile

ChEMBL mechanism, action type and target identity. Open Targets clinical status and indications.

Clinical trials

30

Trials of drugs that target this protein — reached indirectly through those drugs, so a trial listed here studies the drug, not the protein.

Show remaining trials (24)

ClinicalTrials.gov via the drug-target graph.

What's happening now

27

Recent activity around this target, drawn from one canonical event stream. Every item is reached through a drug that targets this protein, so each event is news about that drug rather than about the protein directly.

  1. Label change2026-07-29

    Label change: REMDESIVIR (NDA214787)

    fda · regulatory · fda · via remdesivir

  2. Label change2025-10-07

    Label change: REMDESIVIR (NDA214787)

    fda · regulatory · fda · via remdesivir

  3. Label change2025-08-22

    Label change: REMDESIVIR (NDA214787)

    fda · regulatory · fda · via remdesivir

  4. Label change2025-01-10

    Label change: REMDESIVIR (NDA214787)

    fda · regulatory · fda · via remdesivir

  5. Label change2024-12-19

    Label change: REMDESIVIR (NDA214787)

    fda · regulatory · fda · via remdesivir

  6. Label change2024-06-27

    Label change: REMDESIVIR (NDA214787)

    fda · regulatory · fda · via remdesivir

  7. Indication expanded2024-02-28

    Indication expansion: REMDESIVIR (NDA214787)

    fda · regulatory · fda · via remdesivir

  8. Label change2023-08-23

    Label change: REMDESIVIR (NDA214787)

    fda · regulatory · fda · via remdesivir

  9. Label change2023-08-17

    Label change: REMDESIVIR (NDA214787)

    fda · regulatory · fda · via remdesivir

  10. Indication expanded2023-07-13

    Indication expansion: REMDESIVIR (NDA214787)

    fda · regulatory · fda · via remdesivir

  11. Label change2023-06-12

    Label change: REMDESIVIR (NDA214787)

    fda · regulatory · fda · via remdesivir

  12. Label change2023-06-07

    Label change: REMDESIVIR (NDA214787)

    fda · regulatory · fda · via remdesivir

Objective event titles are shown unmodified; the event kind and significance line are derived from structured fields. Forefront AttentionEvent stream aggregating Europe PMC Regulatory filings ClinicalTrials.gov.